Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PERPHENAZINE vs PEXIDARTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PERPHENAZINE vs PEXIDARTINIB: Safety Overview

Metric PERPHENAZINE PEXIDARTINIB
Total FAERS Reports 927 970
Deaths Reported 82 17
Death Rate 8.8% 1.8%
Hospitalizations 538 91
Average Patient Age 44.4 yrs 44.9 yrs
% Female Patients 46.3% 63.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Aug 2, 2019
Manufacturer Major Pharmaceuticals Daiichi Sankyo Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued